Clinical Research Committee
The Clinical Research Committee oversees funding and endorsement of investigator-led clinical trials, and other research supporting or enabling clinical trials.
Research areas
CRC maintains a broad portfolio that maximises patient impact. We support a balance of research across the range of modalities and disease sites, conducted in early, pre-invasive, localised disease and metastatic settings.
Our investment priorities include:
- Cancers of unmet need (lung, oesophageal, pancreatic and brain cancers)
- Promising, high impact and innovative trials that would not otherwise progress
- Scientifically-driven studies that use and analyse biomarkers and imaging, producing valuable biological and clinical information that will optimise treatments
- Hypothesis-driven, data-rich sample collections that support the validation and qualification of valuable biological information
- Innovative, cost-effective trial designs that can be supported by strategic long-term investments in trial platforms
Funding schemes
| Scheme |
|---|
| Clinical Research Funding Scheme A modular funding scheme that funds high-quality clinical research, associated translational research, and collection of samples and data. |
On occasion, the CRC also reviews strategic initiatives in areas of high strategic priority, such as cancers of unmet need. These are typically large scale, ambitious research proposals which bring together the research community around a specific problem and which, if successful, would result in a significant step forward against the CRUK research strategy. If you would like to discuss such a concept, please get in touch using the contact details below.
More clinical research opportunities
We support a broad portfolio of clinical and translational research through response mode funding, partnership initiatives and investments in clinical infrastructure.
Schemes reviewed by this committee
More like this
Committee and Panel Members
Chair of the Clinical Research Committee
Professor Andrew Tutt - The Institute of Cancer Research
Vice Chairs of the Clinical Research Committee
Professor Frances Balkwill - Queen Mary, University of London
Professor James Brenton – University of Cambridge (Also Chair of the Clinical Expert Review Panel)
Members of the Clinical Research Committee
Professor Gerhardt Attard - University College London
Dr Bristi Basu - The University of Cambridge
Professor Sarah Brown - The University of Leeds
Professor Andy Davies - The University of Southampton
Professor Charlie Gourley - The University of Edinburgh
Professor Alastair Greystoke - Newcastle University
Professor Mariam Jamal-Hanjani - University College London
Professor Simon Leedham - The University of Oxford
Professor Paul Lorigan - The University of Manchester
Dr Stefan Michiels - Gustave Roussy
Dr Jessica Okosun - Queen Mary, University of London/Barts Cancer Institute
Dr Gudrun Schleiermacher - Institute Curie
Professor Christina Yap - The Institute of Cancer Research
Professor James O'Connor - The Institute of Cancer Research/University of Manchester
Mr Christopher Hurt - University of Southampton
Chair of the Clinical Research Monitoring Panel
Dr Natalie Cook - University of Manchester
Vice Chair of the Clinical Research Monitoring Panel
Professor Emma Hall - Institute of Cancer Research
Members of the Clinical Research Monitoring Panel
Professor John Chester - Alder Hey
Dr Graham Collins - University of Oxford
Dr John Moppett - University Hospitals Bristol
Ms Sarah Pearson - University of Oxford
Professor Richard Wilson - University of Glasgow
Mrs Andrea Harkin - University of Glasgow
Dr Vicky Coyle - Queen's University Belfast
Professor Ann Henry - University of Leeds
There are 8 Patient and Public Involvement Representatives supporting our Clinical Research Committee and associated panels as full voting Members:
Ms Caroline Cross
Mr Matthew Baker
Ms Debbie Keatley
Ms Maisie McKenzie
Ms Sonia Patton
Ms Janette Rawlinson
Mr Richard Stephens
Ms Julie Wolfarth
The Clinical Expert Review Panel is chaired by Members of the Clinical Research Committee:
- Professor James Brenton – University of Cambridge (Chair)
The Membership of the Clinical Expert Review Panel is a predominantly ad-hoc Panel with the addition of Standing Panel Members:
- Dr Kim Linton - University of Manchester
- Professor Anthony Moorman - Newcastle University
How proposals are judged
The Committee and its Expert Review Panels meet three times per year and assess all applications on the basis of their scientific quality, taking into consideration comments collected from expert peer reviewers. The Committee strategically assess applications based on their alignment to the Statement of Intent for Clinical Research (PDF), and our Research Strategy.
How grants are monitored
Grants are monitored through the Clinical Research Monitoring Panel (CRMP). The Panel meets three times per year to review annual Scientific Milestone Reports and determine whether to continue support.
To contact this committee
Please email: clinicalresearch@cancer.org.uk